France Environmental Health Policy Review Highlights Chemical Regulation Gaps and PFAS Risks

Fragmented Chemical Regulation and Policy Gaps

The report finds that environmental health policy in France remains “under-designed”, with regulatory frameworks for chemicals dispersed across multiple sectors and institutions. This fragmentation leads to inconsistencies, duplication and gaps in oversight, particularly under EU frameworks such as REACH, which leaves many substances insufficiently evaluated.

More than 350,000 chemicals are estimated to be on the global market, yet research and regulatory capacity lag far behind. The report highlights that risk assessments often rely heavily on industry-provided data, with limited public capacity for independent verification.

For professionals across the chemicals value chain, this signals increasing regulatory uncertainty and the likelihood of stricter future controls, especially as authorities push for more harmonised and precautionary approaches.

PFAS Regulation and Calls for Source Restrictions

PFAS chemicals emerge as a priority concern. The report describes widespread environmental contamination and significant data gaps, with only a fraction of the thousands of PFAS substances adequately studied.

Health risks linked to PFAS include cancers, thyroid disease and developmental effects. The report calls for a “universal restriction at source” and supports treating PFAS as a single class in regulatory frameworks.

This aligns with ongoing EU discussions on broad PFAS restrictions and suggests that companies using fluorinated substances should accelerate substitution strategies and supply chain audits.

Economic and Compliance Implications

The economic burden of environmental exposures is described as “colossal” yet underestimated. Air pollution alone costs tens of billions of euros annually in France, while PFAS-related costs in Europe could reach up to €1.7 trillion by 2050 under certain scenarios.

The report also highlights weak enforcement, limited inspections and insufficient sanctions, raising concerns about uneven compliance across sectors and potential competitive distortions.

Stakeholders including manufacturers, importers and downstream users may face tighter enforcement, expanded monitoring obligations and increased liability under a strengthened polluter-pays principle.

Governance Reform and “One Health” Strategy

To address systemic issues, the report recommends creating a unified “One Health” approach integrating human, animal and environmental health. It also proposes a national strategy with clearer prioritisation of risks, improved data sharing and stronger inter-ministerial coordination.

A key recommendation includes establishing a European “One Health” agency to streamline chemical risk assessment and reduce regulatory fragmentation.